Balsalazide

Balsalazide

is an anti-

Children who have been breast-fed may be at lower risk of subsequently developing IBD than children who have been formula fed. If true, this would mean that there is something potentially harmful in infant formula or, more likely, something protective in breast milk.

used in the treatment of . It is sold under the name “” in the US and “Colazide” in the UK. It is also sold in generic form in the US by several generic manufacturers.
It is usually administered as the .

Balsalazide
Balsalazide

Balsalazide releases mesalazine, also known as 5-, or 5-ASA, in the . Its advantage over that drug in the treatment of ulcerative colitis is believed to be the delivery of the active agent past the to the large intestine, the active site of ulcerative colitis.

Leave a Reply